Australia · Delayed Price · Currency is AUD Compumedics Statistics
Total Valuation
Compumedics has a market cap or net worth of AUD 51.94 million. The enterprise value is 60.49 million.
| Market Cap | 51.94M |
| Enterprise Value | 60.49M |
Important Dates
The next estimated earnings date is Monday, November 23, 2026.
| Earnings Date | Nov 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Compumedics has 199.76 million shares outstanding. The number of shares has increased by 4.87% in one year.
| Current Share Class | 199.76M |
| Shares Outstanding | 199.76M |
| Shares Change (YoY) | +4.87% |
| Shares Change (QoQ) | -52.12% |
| Owned by Insiders (%) | 53.77% |
| Owned by Institutions (%) | 3.74% |
| Float | 71.99M |
Valuation Ratios
The trailing PE ratio is 260.26 and the forward PE ratio is 12.38.
| PE Ratio | 260.26 |
| Forward PE | 12.38 |
| PS Ratio | 0.84 |
| PB Ratio | 2.28 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | 8.04 |
| P/OCF Ratio | 7.83 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.84, with an EV/FCF ratio of 9.37.
| EV / Earnings | 239.11 |
| EV / Sales | 0.98 |
| EV / EBITDA | 12.84 |
| EV / EBIT | 17.58 |
| EV / FCF | 9.37 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.65.
| Current Ratio | 1.22 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 2.28 |
| Interest Coverage | 2.28 |
Financial Efficiency
Return on equity (ROE) is 1.14% and return on invested capital (ROIC) is 1.64%.
| Return on Equity (ROE) | 1.14% |
| Return on Assets (ROA) | 3.85% |
| Return on Invested Capital (ROIC) | 1.64% |
| Return on Capital Employed (ROCE) | 11.91% |
| Weighted Average Cost of Capital (WACC) | 5.30% |
| Revenue Per Employee | 353,583 |
| Profits Per Employee | 1,446 |
| Employee Count | 175 |
| Asset Turnover | 1.11 |
| Inventory Turnover | 2.06 |
Taxes
In the past 12 months, Compumedics has paid 1.44 million in taxes.
| Income Tax | 1.44M |
| Effective Tax Rate | 85.07% |
Stock Price Statistics
The stock price has decreased by -13.33% in the last 52 weeks. The beta is 0.39, so Compumedics's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -13.33% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.29 |
| Relative Strength Index (RSI) | 56.90 |
| Average Volume (20 Days) | 52,925 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Compumedics had revenue of AUD 61.88 million and earned 253,000 in profits. Earnings per share was 0.00.
| Revenue | 61.88M |
| Gross Profit | 32.64M |
| Operating Income | 3.44M |
| Pretax Income | 1.70M |
| Net Income | 253,000 |
| EBITDA | 3.77M |
| EBIT | 3.44M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 6.15 million in cash and 14.70 million in debt, with a net cash position of -8.56 million or -0.04 per share.
| Cash & Cash Equivalents | 6.15M |
| Total Debt | 14.70M |
| Net Cash | -8.56M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | 22.75M |
| Book Value Per Share | 0.11 |
| Working Capital | 6.24M |
Cash Flow
In the last 12 months, operating cash flow was 6.64 million and capital expenditures -181,000, giving a free cash flow of 6.46 million.
| Operating Cash Flow | 6.64M |
| Capital Expenditures | -181,000 |
| Depreciation & Amortization | 333,000 |
| Net Borrowing | 2.23M |
| Free Cash Flow | 6.46M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 52.74%, with operating and profit margins of 5.56% and 0.41%.
| Gross Margin | 52.74% |
| Operating Margin | 5.56% |
| Pretax Margin | 2.74% |
| Profit Margin | 0.41% |
| EBITDA Margin | 6.10% |
| EBIT Margin | 5.56% |
| FCF Margin | 10.43% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 1.92%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 1.92% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.87% |
| Shareholder Yield | -2.95% |
| Earnings Yield | 0.49% |
| FCF Yield | 12.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Compumedics has an Altman Z-Score of 2.04 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.04 |
| Piotroski F-Score | 6 |